Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

NCT01017822 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped This study was withdrawn due to study agent availability.

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: conatumumab
DRUG: capecitabine
DRUG: gemcitabine hydrochloride
RADIATION: 3-dimensional conformal radiation therapy

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]